Objective: This study systematically assessed temporal trends in the global burden of ischemic heart disease (IHD) attributable to high body mass index (BMI) and low physical activity (PA) among women from 1990 to 2021. Methods: Data were obtained from the 2021 Global Burden of Disease Database, which covers disability-adjusted life years (DALYs), mortality rates, years lived with disability (YLDs), years of life lost (YLLs), and age-standardized rates (ASRs) attributable to high BMI and low PA among women. ASRs and estimated annual percentage changes (EAPCs) were calculated over 32 years. Temporal trends were analyzed by country, region, and sociodemographic index (SDI). A decomposition analysis was performed, and future predictions were made using the ARIMA time-series method to assess these trends comprehensively. Results: DALYs associated with IHD attributable to high BMI in women increased from 5.17 million in 1990 to 9.87 million in 2021. Deaths increased from 243,512 to 461,122, YLDs from 85,634 to 238,639, and YLLs from 5.08 to 9.63 million. However, DALYs related to female IHD caused by low PA increased from 146 to 242 million. Deaths increased from 87,707 to 152,305, YLDs from 23,564 to 54,301, and YLLs from 144 to 236 million. Although the ASRs of DALYs, mortality, and YLLs associated with high BMI and low PA have decreased, the ASR of YLDs has remained relatively stable over 32 years. This overall increase in disease burden underscores the urgency of intervention strategies to address the risk factors of high BMI and low PA. Significant regional and national differences were observed, with the burden shifting from high-SDI areas to low- and low-middle-SDI areas, a trend further amplified by population growth and aging. Although overall health inequalities have decreased, predictions indicate that the ASR of female IHD will continue to decline over the next 29 years, whereas the ASR of YLDs is expected to increase. This indicates that although women’s health awareness is increasing, more efforts are needed to maintain cardiovascular health, reduce the burden of IHD, and improve the quality of life for women. Conclusions: Since 1990, high BMI and insufficient PA have substantially contributed to the global burden of IHD in women, with profound variation by age, region, and sociodemographic context. These effects differ from those in men due to women's unique physiological and social roles, underscoring the need for targeted health strategies aimed at women. Nations should focus on managing BMI and promoting physical activity to reduce the IHD burden and inform public health policies to improve women’s cardiovascular health and quality of life.
Di Cesare M, Perel P, Taylor S, et al., 2024, The Heart of the World. Global Heart, 19(1): 11.
Virani SS, Alonso A, Aparicio HJ, et al., 2021, Heart Disease and Stroke Statistics-2021 Update: A Report from the American Heart Association. Circulation, 143(8): e254–e743.
Taqueti VR, 2018, Sex Differences in the Coronary System. Advances in Experimental Medicine and Biology, 1065: 257–278.
Shin J, Lee S, Kim TH, et al., 2019, Effects of Lifestyle-Related Factors on Ischemic Heart Disease According to Body Mass Index and Fasting Blood Glucose Levels in Korean Adults. PLoS One, 14(5): e0216534.
Wang W, Hu M, Liu H, et al., 2021, Global Burden of Disease Study 2019 Suggests That Metabolic Risk Factors Are the Leading Drivers of the Burden of Ischemic Heart Disease. Cell Metabolism, 33: 1943–1956.
Lin W, Fu Z, Chen C, et al., 2025, Global, Regional and National Burden of Ischaemic Heart Disease Attributable to High Body Mass Index from 1990 to 2021: A Systematic Analysis for the Global Burden of Disease Study 2021. BMC Public Health, 27(5): 2561–2572.
Hou Y, Miao H, Xie W, et al., 2026, Global Burden of Ischemic Heart Disease Attributable to Low Physical Activity in Adults > 40 Years, 1990–2021 and Projections to 2046: A GBD 2021 Analysis. Journal of Science and Medicine in Sport, 29(7): 755–764.
Miranda VPN, Dos Santos Amorim PR, Bastos RR, et al., 2019, Evaluation of Lifestyle of Female Adolescents Through Latent Class Analysis Approach. BMC Public Health, 19(1): 184.
GBD 2021 Diseases and Injuries Collaborators, 2024, Global Incidence, Prevalence, Years Lived with Disability (YLDs), Disability Adjusted Life-Years (DALYs), and Healthy Life Expectancy (HALE) for 371 Diseases and Injuries in 204 Countries and Territories and 811 Subnational Locations, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021. The Lancet, 403: 2133–2161.
GBD 2021 Risk Factors Collaborators, 2024, Global Burden and Strength of Evidence for 88 Risk Factors in 204 Countries and 811 Subnational Locations, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021. The Lancet, 403: 2162–2203.
Yang X, Zhang T, Zhang X, et al., 2022, Global Burden of Lung Cancer Attributable to Ambient Fine Particulate Matter Pollution in 204 Countries and Territories, 1990–2019. Environmental Research, 204(Pt A): 112023.
GBD 2017 Risk Factor Collaborators, 2018, Global, Regional, and National Comparative Risk Assessment of 84 Behavioral, Environmental and Occupational, and Metabolic Risks or Clusters of Risks for 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017. The Lancet, 392(10159): 1923–1994.
Das Gupta P, 1978, A General Method of Decomposing a Difference Between Two Rates into Several Components. Demography, 15: 99–112.
Nelson BK, 1998, Statistical Methodology: V. Time Series Analysis Using Autoregressive Integrated Moving Average (ARIMA) Models. Academic Emergency Medicine, 5(7): 739–744.
Chen J, Cui Y, Deng Y, et al., 2024, Global, Regional, and National Burden of Cancers Attributable to Particulate Matter Pollution from 1990 to 2019 and Projection to 2050: Worsening or Improving? Journal of Hazardous Materials, 477: 135319.
GBD 2021 Causes of Death Collaborators, 2024, Global Burden of 288 Causes of Death and Life Expectancy Decomposition in 204 Countries and Territories and 811 Subnational Locations, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021. The Lancet, 403(10440): 2100–2132.
Uddenberg ER, Ward K, Murrell K, et al., 2024, Menopause Transition and Cardiovascular Disease Risk. Nature Reviews Cardiology, 185: 107974.
Aggio D, Papachristou E, Papacosta O, et al., 2020, Trajectories of Physical Activity from Midlife to Old Age and Associations with Subsequent Cardiovascular Disease and All-Cause Mortality. Journal of Epidemiology and Community Health, 74(2): 130–136.
Kaneko H, Suzuki Y, Ueno K, et al., 2022, Association of Life's Simple 7 with Incident Cardiovascular Disease in 53,974 Patients with Cancer. European Journal of Preventive Cardiology, 29(18): 2324–2332.
Misra A, 2020, Dietary Cholesterol Advisory from American Heart Association: Implications for India and Other Developing Countries. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14: 107–108.
Wang C, Li Y, Shi J, et al., 2021, Risk-Attributable Burden of Ischemic Heart Disease in 137 Low- and Middle-Income Countries. Frontiers in Cardiovascular Medicine, 10(19): e021024.
Trecarten N, Kirkland S, Rainham D, et al., 2021, Location-Based Sedentary Time and Physical Activity in People Living with Coronary Artery Disease. Journal of Cardiopulmonary Rehabilitation and Prevention, 41(4): 337–342.
Bhattacharyya O, Shaw J, Sinha S, et al., 2020, Innovative Integrated Health and Social Care Programs in Eleven High-Income Countries. Health Affairs, 39(4): 689–696.
Budreviciute A, Damiati S, Sabir DK, et al., 2020, Management and Prevention Strategies for Non-Communicable Diseases (NCDs) and Their Risk Factors. Frontiers in Public Health, 8: 574111.
Arnett DK, Blumenthal RS, Albert MA, et al., 2019, 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, 140(11): e563–e595.
Tanaka Y, Joki N, Hase H, 2015, Ischemic Heart Disease in Patients with End-Stage Kidney Disease. Blood Purification, 40(4): 332–336.